Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | -3.23% |
|
-4.12% | -70.32% |
Jul. 01 | NovaBay Pharmaceuticals, Eyenovia Begin Co-Promotion Deal Activities | MT |
Jul. 01 | NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. Commence Co-Promotion Activities | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.32% | 2.5M | |
+16.97% | 44.44B | |
+42.72% | 40.03B | |
-10.64% | 37.68B | |
+30.37% | 31.46B | |
-9.23% | 27.29B | |
+12.44% | 26.29B | |
+42.42% | 13.8B | |
+30.07% | 12.46B | |
-7.63% | 11.26B |
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals, Inc.
- Transcript : NovaBay Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022